Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWt India Earn Regulatory News (EPI)

Share Price Information for Wt India Earn (EPI)

Share Price is delayed by 15 minutes
Get Live Data
23.01    -0.3725 (-1.60%)
Bid:
22.89
Ask:
22.995
Spread: 0.105 (0.459%)
Market Cap: -
EPI Live PriceLast checked at - London Stock Exchange

Intraday Wt India Earn Share Chart

Offer Update

25 Aug 2005 17:12

Huveaux PLC25 August 2005 Not for release, publication or distribution in or into the United States,Australia, Canada, Japan or any other jurisdiction if to do so would constitutea violation of the relevant laws of such jurisdiction For immediate release 25 August 2005 Recommended Offer by Dresdner Kleinwort Wasserstein Limited on behalf of Huveaux PLC ("Huveaux") for Epic Group plc ("Epic") Posting of compulsory acquisition notice Huveaux announces that as at 3.00 p.m. on 25 August 2005, valid acceptances ofthe Offer had been received in respect of 21,802,647 Epic Shares, representingapproximately 90.16 per cent. of the existing issued ordinary share capital ofEpic. As valid acceptances of the Offer have been received in respect of more than 90per cent. in value of Epic Shares to which the Offer relates, Huveaux intends toapply the provisions of sections 428-430F of the Companies Act 1985 to acquirecompulsorily all outstanding Epic Shares under the terms of the Offer.Accordingly, Huveaux will be shortly posting formal notices under section 429 ofthe Companies Act 1985 to Epic Shareholders who have not yet accepted the Offer. The Offer will remain open until further notice. As previously announced, application has been made to the London Stock Exchangefor the trading of Epic Shares on AIM to be cancelled. The cancellation ofadmission will take effect on 20 September 2005. Words and expressions defined in the Offer Document dated 28 July 2005 shallhave the same meaning when used in this announcement. Copies of the documentsposted to Epic Shareholders on 28 July 2005 are available for inspection at theDocument Viewing Facility of the UK Listing Authority at The Financial ServicesAuthority, 25 The North Colonnade, London E14 5HS. Enquiries: Huveaux 020 7245 0270John van Kuffeler, Executive Chairman Dresdner Kleinwort Wasserstein (Financial advisor to Huveaux) 020 7623 8000Charles BattenJoe Thompson Finsbury (Public Relations advisor to Huveaux) 020 7251 3801James LevitonKatie LangDon Hunter Dresdner Kleinwort Wasserstein, which is authorised and regulated by theFinancial Services Authority, is acting for Huveaux and for no-one else inconnection with the Offer and will not be responsible to anyone other thanHuveaux for providing the protections afforded to customers of DresdnerKleinwort Wasserstein, or for providing advice in relation to the Offer or anymatters referred to herein. This information is provided by RNS The company news service from the London Stock Exchange
12
Date   Source Headline
15th Jul 200511:19 amRNSRule 8.3 - Epic Group
15th Jul 200510:44 amRNSRule 8.3- (Epic Group PLC)
14th Jul 20057:00 amRNSFinal Results
13th Jul 200510:30 amRNSNotice of Results
12th Jul 200510:51 amRNSEPT Disclosure
6th Jul 20058:48 amRNSEPT Disclosure
4th Jul 20059:41 amRNSEPT Disclosure
30th Jun 20059:45 amRNSEPT Disclosure
30th Jun 20059:45 amRNSEPT Disclosure
29th Jun 200511:33 amRNSEPT Disclosure
28th Jun 200510:46 amRNSStatement re Possible Offer
1st Jun 20057:01 amRNSHolding(s) in Company
10th May 200512:26 pmRNSHolding(s) in Company
9th May 200511:02 amRNSDirector Shareholding
13th Apr 200512:45 pmRNSResult of EGM
11th Mar 20053:07 pmRNSDirector Shareholding
11th Mar 20053:05 pmRNSHolding(s) in Company
10th Mar 20058:39 amRNSCapital Reorganisation
22nd Feb 200510:24 amRNSAdditional Listing
15th Feb 20055:12 pmRNSHolding(s) in Company
9th Feb 20052:18 pmRNSAdditional Listing
8th Feb 200512:33 pmRNSHolding(s) in Company
1st Feb 200511:16 amRNSDividend Date-Amendment
1st Feb 20057:00 amRNSInterim Results
12th Jan 20057:00 amRNSNotice of Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.